Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012)

被引:6
作者
Eshleman, SH
Guay, LA
Fleming, T
Mwatha, A
Mracna, M
Becker-Pergola, G
Musoke, P
Mmiro, F
Jackson, JB
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Makerere Univ, Dept Pediat, Kampala, Uganda
[4] Makerere Univ, Dept Obstet & Gynaecol, Kampala, Uganda
关键词
HIV-1; Uganda; subtype; nevirapine; zidovudine; infant;
D O I
10.1097/00126334-200211010-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Virologic factors may influence survival of HIV-1-infected infants. We compared survival of Ugandan infants with subtype A and subtype D HIV-1 infection. This study was performed in the context of the Ugandan clinical trial HIVNET 012, which compared the efficacy of single-dose nevirapine (NVP) and short-course zidovudine (AZT) for prevention of HIV-1 mother-to-child transmission. HIV-1 sub-types were determined by phylogenetic analysis of HIV-1 protease and reverse transcriptase sequences from 32 women in the NVP arm and 54 women in the AZT arm of HIVNET 0 12 whose infants were HIV-1 infected by 6 to 8 weeks of age. We found no association between HIV-1 subtype (A vs. D) and infant survival in this cohort. Further studies are needed to evaluate whether HIV-1 subtype influences clinical outcome in pediatric HIV-1 infection.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 21 条
[1]   Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D [J].
Alaeus, A ;
Lidman, K ;
Björkman, A ;
Giesecke, J ;
Albert, J .
AIDS, 1999, 13 (08) :901-907
[2]  
Barnhart HX, 1996, PEDIATRICS, V97, P710
[3]   LONGITUDINAL-STUDY OF 94 SYMPTOMATIC INFANTS WITH PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - EVIDENCE FOR A BIMODAL EXPRESSION OF CLINICAL AND BIOLOGICAL SYMPTOMS [J].
BLANCHE, S ;
TARDIEU, M ;
DULIEGE, AM ;
ROUZIOUX, C ;
LEDEIST, F ;
FUKUNAGA, K ;
CANIGLIA, M ;
JACOMET, C ;
MESSIAH, A ;
GRISCELLI, C .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (11) :1210-1215
[4]   REPLICATION AND TROPISM OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AS PREDICTORS OF DISEASE OUTCOME IN INFANTS WITH VERTICALLY ACQUIRED INFECTION [J].
DEROSSI, A ;
GIAQUINTO, C ;
OMETTO, L ;
MAMMANO, F ;
ZANOTTO, C ;
DUNN, D ;
CHIECOBIANCHI, L .
JOURNAL OF PEDIATRICS, 1993, 123 (06) :929-936
[5]   Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: Importance of viral RNA and the timing of transmission on long-term outcome [J].
Dickover, RE ;
Dillon, M ;
Leung, KM ;
Krogstad, P ;
Plaeger, S ;
Kwok, S ;
Christopherson, C ;
Deveikis, A ;
Keller, M ;
Stiehm, ER ;
Bryson, YJ .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :375-387
[6]   RAPID INCREASES IN LOAD OF HUMAN-IMMUNODEFICIENCY-VIRUS CORRELATE WITH EARLY DISEASE PROGRESSION AND LOSS OF CD4 CELLS IN VERTICALLY INFECTED INFANTS [J].
DICKOVER, RE ;
DILLON, M ;
GILLETTE, SG ;
DEVEIKIS, A ;
KELLER, M ;
PLAEGERMARSHALL, S ;
CHEN, I ;
DIAGNE, A ;
STIEHM, ER ;
BRYSON, Y .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1279-1284
[7]   Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 study) [J].
Eshleman, SH ;
Becker-Pergola, G ;
Deseyve, M ;
Guay, LA ;
Mracna, M ;
Fleming, T ;
Cunningham, S ;
Musoke, P ;
Mmiro, F ;
Jackson, JB .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (07) :914-917
[8]   Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) [J].
Eshleman, SH ;
Mracna, M ;
Guay, LA ;
Deseyve, M ;
Cunningham, S ;
Mirochnick, M ;
Musoke, P ;
Fleming, T ;
Fowler, MG ;
Mofenson, LM ;
Mmiro, F ;
Jackson, JB .
AIDS, 2001, 15 (15) :1951-1957
[9]   African HIV-1 subtype C and rate of progression among ethiopian immigrants in Israel [J].
Galai, N ;
Kalinkovich, A ;
Burstein, R ;
Vlahov, D ;
Bentwich, Z .
LANCET, 1997, 349 (9046) :180-181
[10]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial [J].
Guay, LA ;
Musoke, P ;
Fleming, T ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Ducar, C ;
Deseyve, M ;
Emel, L ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Dransfield, K ;
Bray, D ;
Mmiro, F ;
Jackson, JB .
LANCET, 1999, 354 (9181) :795-802